Collaborative Health Apps

The uMotif is Designed to Give Clinicians Broad Patient Info

While there is a deluge of health-tracking apps hitting app markets in recent years, uMotif may be the first one designed specifically to be used collaboratively between patients and clinicians. The app aims to improve both the quality and quantity of patient information available to doctors.

The app is used to track a variety of aspects of users' lives, including both subjective measures such as mood and objective metrics such as weight and glucose levels. The data aims to provide clinicians with a wide-ranging set of data to lend context to patient treatment and care.

uMotif is set to launch first in the UK on both the iOS and Android platforms, and will be introduced in 15 National Health Services (NHS) centers. The company plans to expand availability in the next couple of years.

Collaborative Health Tracking
Creating apps that facilitate collaboration between patients and clinicians to improve healthcare outcomes.
Patient-centric Data Collection
Developing apps that collect a wide range of subjective and objective data to provide context for patient treatment and care.
Expansion of Health App Availability
Increasing the availability of health-tracking apps in healthcare centers and clinics to enhance patient care and information sharing.

Who This Affects Most

Healthcare Technology
Incorporating collaborative health apps into healthcare technology to improve patient-clinician communication and treatment.
Mobile App Development
Harnessing patient-centric data collection to create innovative health-tracking apps for mobile devices.
Digital Health Services
Expanding the use of health apps in healthcare centers and clinics to better serve patients and enhance their overall healthcare experience.
SCORE
2.4 out of 10
GENDER
70% Men30% Women
MARKETTop markets: North America, Europe
GENERATION
  • Gen Z
  • Gen Alpha
  • Millennial (primary audience)
  • Gen X (primary audience)
POPULARITY
Popularity 18%
Activity 45%
Freshness 8%